UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015891
Receipt No. R000017676
Official scientific title of the study Study to evaluate the clinical effectiveness of intermittent infusion hemodiafiltration (I-HDF)
Date of disclosure of the study information 2014/12/10
Last modified on 2017/04/27 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study to evaluate the clinical effectiveness of intermittent infusion hemodiafiltration (I-HDF)
Title of the study (Brief title) Study to evaluate the clinical effectiveness of I-HDF
Region
Japan

Condition
Condition Chronic Kidney Failure
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the clinical condition and quality of life (QOL) of I-HDF compared with HD.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes SF-36 ver2
Clinical condition (VAS scale)
Key secondary outcomes Vital signs (blood pressure, pulse)
Number of treatments by medical staff
Blood test
Dose of erythropoietin-stimulating agent
Solute removal ability

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment Maneuver
Interventions/Control_1 HD therapy (for 3 months) --> I-HDF therapy (for 3 months) --> HD therapy (for 3 months)
Interventions/Control_2 I-HDF therapy (for 3 months) --> HD therapy (for 3 months) --> I-HDF therapy (for 3 months)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Hemodialysis patient who on-line HDF therapy is possible, and can give written informed consent
- 18 years and over
- Hemodialysis for more than 6 months
Key exclusion criteria 1) Patients with severe cardiovascular disease (NYHA class 3 or 4), hepatic failure, respiratory failure, or malignant tumor
2) 8% or more of the rate of weight gain
3) Patients who are judged ineligible by the attending physician.
Target sample size 70

Research contact person
Name of lead principal investigator Michio Mineshima
Organization Tokyo Women's Medical University
Division name Department of Clinical Engineering
Address 8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL 03-3353-8111
Email mmine@twmu.ac.jp

Public contact
Name of contact person Ryoichi Sakiyama
Organization Tokyo Women's Medical University
Division name Department of Clinical Engineering
Address 8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL 03-3353-8111
Homepage URL
Email sakiyama@twmu.ac.jp

Sponsor
Institute I-HDF Multicenter Study Group
Institute
Department

Funding Source
Organization JMS Co., Ltd.
Asahi Kasei Medical Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 常磐病院(福島県)
名港共立クリニック(愛知県)
偕行会城西病院(愛知県)
偕行会セントラルクリニック(愛知県)
鴨島川島クリニック(徳島県)
鳴門川島クリニック(徳島県)
中島土谷クリニック(広島県)
大町土谷クリニック(広島県)
新古賀クリニック(福岡県)
古賀病院21(福岡県)
伊都クリニック(福岡県)
たかみや医院(熊本県)

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 06 Month 24 Day
Anticipated trial start date
2014 Year 09 Month 18 Day
Last follow-up date
2014 Year 11 Month 30 Day
Date of closure to data entry
2015 Year 10 Month 01 Day
Date trial data considered complete
2016 Year 06 Month 30 Day
Date analysis concluded
2017 Year 04 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 12 Month 10 Day
Last modified on
2017 Year 04 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017676